SCHEMBL6985352

SCHEMBL6985352

CCOC(=O)Cc1nc(O)c(=O)[nH]c1C

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.51
KDM4E B2RXH2 3/20 0.49
ALDH1A1 P00352 4/20 0.46
SMN1; SMN2 Q16637 4/20 0.46
HSD17B10 Q99714 4/20 0.45
USP2 O75604 1/20 0.45
TSHR P16473 1/20 0.45
HPGD P15428 1/20 0.43
KMT2A Q03164 2/20 0.41
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.40
LMNA P02545 2/20 0.40
MAPT P10636 1/20 0.40
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA9 Q16790 1/20 0.40
POLB P06746 2/20 0.39
TRPM8 Q7Z2W7 1/20 0.38
RECQL P46063 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7374513 0.83 MAPK1 (0.47) MAPK1KDM4EALDH1A1SMN1; SMN2HSD17B10
SCHEMBL6988539 0.83 MAPK1 (0.47) MAPK1KDM4EALDH1A1SMN1; SMN2HSD17B10
SCHEMBL7391592 0.80 MAPK1 (0.47) MAPK1KDM4EALDH1A1SMN1; SMN2HSD17B10
SCHEMBL27741354 0.73 MAPK1 (0.46) MAPK1KDM4EALDH1A1SMN1; SMN2HSD17B10
SCHEMBL11857906 0.71 SMPD3 (0.48) MAPK1KDM4EALDH1A1SMN1; SMN2HSD17B10
SCHEMBL6216796 0.71 HSD17B10 (0.63) MAPK1KDM4EALDH1A1SMN1; SMN2HSD17B10
SCHEMBL27286224 0.70 MAPK1 (0.73) MAPK1KDM4EALDH1A1HSD17B10USP2
SCHEMBL7445391 0.69 SMN1; SMN2 (0.49) MAPK1KDM4EALDH1A1SMN1; SMN2HSD17B10
SCHEMBL13054440 0.69 KDM4E (0.67) MAPK1KDM4EALDH1A1SMN1; SMN2HSD17B10
SCHEMBL11863144 0.68 MAPT (0.49) MAPK1KDM4EALDH1A1SMN1; SMN2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1303510-A2 CYCLIC OXYGUANIDINE PYRAZINONES AS PROTEASE INHIBITORS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2003-04-23 EP disclosed
EP-1079835-A4 PYRAZINONE THROMBIN INHIBITORS MERCK & CO INC (US) 2002-10-29 EP disclosed
WO-2002009711-A1 THROMBIN INHIBITORS MERCK & CO., INC. (US) 2002-02-07 WO disclosed
WO-2002006248-A2 CYCLIC OXYGUANIDINE PYRAZINONES AS PROTEASE INHIBITORS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2002-01-24 WO disclosed
EP-1017393-A4 PYRAZINONE THROMBIN INHIBITORS MERCK & CO INC (US) 2002-01-23 EP disclosed
EP-1079835-A1 PYRAZINONE THROMBIN INHIBITORS Merck & Co., Inc. (US) 2001-03-07 EP disclosed
EP-1017393-A1 PYRAZINONE THROMBIN INHIBITORS Merck & Co., Inc. (US) 2000-07-12 EP disclosed
WO-1999059591-A1 PYRAZINONE THROMBIN INHIBITORS MERCK & CO., INC. (US) 1999-11-25 WO disclosed
WO-1999011267-A1 PYRAZINONE THROMBIN INHIBITORS MERCK & CO., INC. (US) 1999-03-11 WO disclosed